Almirall SA (ALMRY)
14.28
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Almirall Profit Margin (Quarterly) : 7.72% for None
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.72% |
| December 31, 2025 | |
| June 30, 2025 | |
| December 31, 2024 | |
| June 30, 2024 | |
| December 31, 2023 | |
| June 30, 2023 | |
| December 31, 2022 | |
| June 30, 2022 | |
| December 31, 2021 | |
| June 30, 2021 | |
| December 31, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| June 30, 2019 | |
| December 31, 2018 | |
| June 30, 2018 | |
| December 31, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | |
| June 30, 2016 | |
| December 31, 2015 | 35.63% |
| June 30, 2015 | 8.86% |
| December 31, 2014 | |
| June 30, 2014 | 4.21% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 39.09% |
| Eli Lilly & Co. | 30.88% |
| AstraZeneca PLC | 20.15% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | 64.43% |
| Operating Margin (Quarterly) | 64.43% |